StonvexLoading…
StonvexStonvexStonvexCore line items from ADAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $601.95M | $401.28M | $258.66M | $258.39M |
Operating Income | $137.80M | $-92.92M | $-77.72M | $-340.11M |
Net Income | $149.05M | $-62.03M | $-48.66M | $-298.61M |
EPS (Diluted) | $1.10 | $-1.14 | $-0.99 | $-3.61 |
Total Assets | $12.64B | $9.22B | $7.40B | $6.24B |
Total Liabilities | $11.21B | $7.81B | $5.77B | $4.38B |
Cash & Equivalents | $210.33M | $167.42M | $187.11M | $244.72M |
Free Cash Flow OCF − CapEx | $125.89M | $-10.58M | $-20.46M | $-117.59M |
Shares Outstanding | 90.30M | 90.57M | 90.68M | 91.19M |